Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,680.00    22.00 (1.33%)
Bid:
1,680.00
Ask:
1,684.00
Spread: 4.00 (0.238%)
Market Cap: £494.79m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Filter Contract Award

20 Dec 2011 09:45

RNS Number : 3098U
Avon Rubber PLC
20 December 2011
 



20 December 2011

FILTER CONTRACT AWARD

Avon is pleased to announce that it has received a 5 year contract from the Department of Defense (DoD) for the supply of spare filters for its M50 respirator. Like previous contracts for spare filters, the contract is an Indefinite Delivery Indefinite Quantity ("IDIQ") contract and has a maximum order quantity of 2.4m filter pairs per year and 12m filter pairs over the contract term. The contract also allows the DoD to extend the term by 2 further option years, potentially extending the duration to 7 years. An initial order has been placed by the DoD with a value of $2.5m for immediate delivery.

This new contract is in addition to the existing sole source $38m, 3 year IDIQ contract announced in August. Avon has also received a further delivery order against this contact with a value of $6.1m for delivery by 1 April 2012.

As expected, the DoD has chosen to dual source the procurement of spare filters and another source has also been selected for a 5 year contract award. The Directors believe that it will take up to 2 years for a comparable product to be developed and approved, after which orders for filters for the M50 mask will be competitively bid. The supply of filters with M50 mask systems will remain sole sourced to Avon.

Commenting on the news, Peter Slabbert, Chief Executive said: "We are delighted to have been awarded this new contract which confirms Avon's position as a supplier of consumable filters to the DoD for a further 5 to 7 years. The procurement of the filter for the M50 mask from another supplier was expected and we believe that our state of the art manufacturing capability, our existing technology advantage and the continuation of the sole source window for up to another 2 years will allow Avon to retain its competitive advantage. We are also committed to widening our capability and product range in the area of filtration to enable us to continue to grow this repeat revenue stream."

For further enquiries, please contact:

Avon Rubber p.l.c.

Peter Slabbert, Chief Executive

01225 896 870

Andrew Lewis, Group Finance Director

01225 896 830

Fiona Stewart, Corporate Communications Executive

01225 896 871

Weber Shandwick Financial

Nick Oborne

020 7067 0700

Stephanie Badjonat

020 7067 0700

 

NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder, emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and tubing for the automated milking process. For further information please visit the Group's website www.avon-rubber.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTGCBDDRDDBGBG
Date   Source Headline
15th May 20251:00 pmRNSHolding(s) in Company
7th May 202510:00 amRNSDirectors'/PDMR Shareholding
6th May 202512:00 pmRNS-RNotice of Results & Investor Presentation via IMC
11th Apr 20254:00 pmRNSHolding(s) in Company
8th Apr 202511:00 amRNSDirectors'/PDMR Shareholding
27th Mar 20252:00 pmRNSHolding(s) in Company
26th Mar 20257:00 amRNSQ2 trading update
20th Mar 202510:00 amRNSHolding(s) in Company
11th Mar 20255:00 pmRNSDirector/PDMR Shareholding
6th Mar 20253:00 pmRNSDirectors'/PDMR Shareholdings
4th Mar 20254:00 pmRNSHolding(s) in Company
3rd Mar 20257:00 amRNSNext Generation IHPS Delivery Order
14th Feb 20252:00 pmRNSDirectors'/PDMR Shareholding
11th Feb 20254:00 pmRNSHolding(s) in Company
7th Feb 20254:00 pmRNSFinal Dividend Currency Exchange Rate
5th Feb 20254:00 pmRNSDirectors'/PDMR Shareholdings
31st Jan 202512:00 pmRNSResult of AGM
31st Jan 20257:00 amRNSAGM Statement
27th Jan 20253:00 pmRNSHolding(s) in Company
9th Jan 20257:00 amRNSThales UK Contract Renewal
7th Jan 20259:00 amRNSDirectors'/PDMR Shareholding
6th Jan 20257:00 amRNSNext Generation IHPS Delivery Order
12th Dec 20242:00 pmRNSHolding in Company
10th Dec 20249:00 amRNSNotice of Annual Report & Accounts and AGM 2025
6th Dec 202411:00 amRNSDirectors'/PDMR Shareholding
28th Nov 20245:00 pmRNSDirector/PDMR Shareholding
19th Nov 20242:00 pmRNSDirector/PDMR Shareholding
19th Nov 20247:00 amRNSPreliminary Results
6th Nov 20242:00 pmRNSHolding in Company
6th Nov 202410:00 amRNSDirectors'/PDMR Shareholding
25th Oct 202411:05 amRNSAppointment of Joint Corporate Broker
22nd Oct 20247:00 amRNSNotice of Results
8th Oct 202410:00 amRNSDirectors'/PDMR Shareholding
2nd Oct 20243:05 pmRNSHolding(s) in Company
26th Sep 20246:05 pmRNSHolding(s) in Company
10th Sep 20243:30 pmRNSDirector/PDMR Shareholding
15th Aug 20247:00 amRNSInterim Dividend Currency Exchange Rate
7th Aug 20249:00 amRNSDirectors'/PDMR Shareholdings
1st Aug 20248:19 amRNSChange of Company Name
1st Aug 20247:00 amRNSHolding(s) in Company
29th Jul 202412:00 pmRNSPDMR Shareholdings
25th Jul 20247:00 amRNSNew delivery order & updated FY 2024 guidance
10th Jul 20249:00 amRNSNotification of transaction of PDMR
8th Jul 202412:00 pmRNSDirectors'/PDMR Shareholdings
6th Jun 20243:00 pmRNSDirectors'/PDMR Shareholdings
30th May 20245:00 pmRNSHolding(s) in Company
28th May 20245:00 pmRNSHolding(s) in Company
24th May 20244:00 pmRNSHolding(s) in Company
21st May 20247:04 amRNSInterim Results
9th May 20247:00 amRNSUK MoD General Service Respirator order

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.